CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • AACR20 Day 1 Highlights: Breast Cancer, Lung Cancer, and the Microbiome

    The first day of the 2020 AACR Annual Meeting shared latest data from immunotherapy clinical trials in…

    April 28, 2020| Arthur N. Brodsky, PhD
  • Vaccine-Chemo Combo Shows Promise in Treating Advanced, HPV-Associated Cervical Cancer

    Combined with chemotherapy, an HPV-targeting vaccine developed by CRI scientists led to encouraging responses in women with…

    March 27, 2020| Arthur N. Brodsky, PhD
  • CICON19 Day 3 Update: Vaccines and Tumor Antigens, Technology and Informatics, and the Tumor Microenvironment

    Day 3 of CICON19 explored current strategies to identify tumor neoantigens and develop vaccines as well as advances…

    September 27, 2019| Arthur N. Brodsky, PhD
  • CICON19 Day 1 Update: Cancer Prevention and Combination Immunotherapy Strategies

    Day 1 of CICON19 explored how checkpoint immunotherapy might be improved through combination strategies as well as…

    September 25, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 3 Update: Immunotherapy for Brain Cancer, Ovarian Cancer, Lung Cancer, and Patients with HIV

    The third day at ASCO19 highlighted immunotherapy strategies for patients with brain cancer, ovarian cancer, lung cancer,…

    June 3, 2019| Arthur N. Brodsky, PhD
  • Dr. Robert Schreiber and Interferon Gamma

    By redefining our understanding of the relationship between cancer and the immune system, Dr. Robert Schreiber has…

    May 16, 2019| Arthur N. Brodsky, PhD
  • AACR19 Day 5 Update: Bispecific Antibodies, the Importance of “Helper” T Cells, and the Lloyd J. Old Award Lecture

    Scientists tackled novel immunotherapy strategies that could potentially enable more patients with more types of cancer to…

    April 3, 2019| Arthur N. Brodsky, PhD
  • AACR19 Day 3 Update: CAR T Cells, Vaccines, and Hope Against Pancreatic Cancer

    In addition to advances involving CAR T cell therapy and vaccines, a CRI-funded trial revealed the promise…

    April 1, 2019| Arthur N. Brodsky, PhD
  • AACR19 Preview: CRI Scientists Showcase the Future of Immunotherapy

    The 2019 AACR annual meeting kicks off March 29 in Atlanta and will feature the work of…

    March 23, 2019| Arthur N. Brodsky, PhD
Previous Page
1 2 3
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute